[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367914-105":3,"detail-sidebar-cat-0-en-105":80,"doc-detail-367914-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":73,"head_meta":75,"extra_data":77,"updated_unix":79},105,"en","a-histone-acetylation-based-predictive-model-for-immunotherapy-response-and-combinatorial-targeting-in-cervical-cancer","A histone acetylation-based predictive model for immunotherapy response and combinatorial targeting in cervical cancer","","Histone acetylation, an epigenetic modification, is investigated for its clinical value in cervical cancer prognosis. Using GSE44001 and TCGA-CESC datasets, a HAT-associated prognostic model based on 7 key genes is built via Lasso-Cox regression. Multiple bioinformatics methods characterize immune microenvironments across risk groups, while molecular docking screens two candidate target drugs. The model is validated in an independent cohort, showing a strongly immunosuppressive high-risk phenotype, and identifies CPE and PGK1 as additional prognostic factors linked to poor outcomes.",{"@graph":14,"@context":72},[15,34,55],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/a-histone-acetylation-based-predictive-model-for-immunotherapy-response-and-combinatorial-targeting-in-cervical-cancer/367914/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/a-histone-acetylation-based-predictive-model-for-immunotherapy-response-and-combinatorial-targeting-in-cervical-cancer/367914.png","ImageObject",300,407,{"name":42,"@type":43},"Well Done","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":33},"InteractionCounter",{"@type":54},"ViewAction",{"@type":56,"mainEntity":57},"FAQPage",[58,64,68],{"name":59,"@type":60,"acceptedAnswer":61},"What is the main purpose of the study on histone acetylation in cervical cancer?","Question",{"text":62,"@type":63},"To evaluate the clinical value of histone acetylation modifications for prognostic assessment and to build a predictive model linked to immunotherapy response and drug targeting.","Answer",{"name":65,"@type":60,"acceptedAnswer":66},"How is the prognostic model constructed and what genes are included?",{"text":67,"@type":63},"The study formulates a HAT-associated prognostic model using GSE44001 and TCGA-CESC, with 7 pivotal genes selected through Lasso-Cox regression.",{"name":69,"@type":60,"acceptedAnswer":70},"What drugs and prognostic factors does the study identify?",{"text":71,"@type":63},"Two potential target drugs are screened using molecular docking, and two additional prognostic factors, CPE and PGK1, are identified as significantly associated with poor clinical outcomes.","https://schema.org",{"og:url":32,"og:type":74,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":76,"canonical":32},"index,follow",{"doc_id":78,"site_id":7},367914,1792548178,{"code":4,"msg":81,"data":82},"success",[83,87,91,95,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":84,"show_sort_weight":85,"slug":86},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":88,"show_sort_weight":89,"slug":90},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":92,"show_sort_weight":93,"slug":94},"Exam",70,"exam",{"id":96,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},5,"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":96,"slug":129},19,"General","general",{"code":4,"msg":81,"data":131},{"doc_id":78,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":33,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":127,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},5909892210082,"https://ap-avatar.wpscdn.com/avatar/56001069da27c9f41e8?x-image-process=image/resize,m_fixed,w_180,h_180&k=1789614185077863061","®  \n Observational Study   \nA histone acetylation-based predictive model for immunotherapy response and combinatorial targeting in cervical cancer  \nXinwei Zhang, MMa,b , Meifang Li, MMc , Kun Wang, MMa,b , Zhouna Sun, MMa , Junjie Mao, MMa , Li Zhang, MMa,* , Rui Ji, MMa  \n\n| Abstract\u003Cbr>Histone acetylation, a fundamental component of epigenetic modification, plays a pivotal role in the progression, treatment, and prognosis of numerous cancers. In this study, we systematically investigated, for the first time, the clinical value of histone acetylation (HAT) modification in the prognostic assessment of cervical cancer. Utilizing the GSE44001 and The Cancer Genome Atlas-CESC databases, a HAT-associated prognostic model comprising 7 pivotal genes was formulated through Lasso-Cox regression analysis. The integration of multiple bioinformatics algorithms (including Cibersort, ESTIMATE, ssGSEA, and TIDE) has enabled the profound delineation of immune microenvironmental characteristics among disparate risk groups. Utilizing molecular docking technology, we conducted a screening process that identified 2 potential target drugs. The prognostic model’s predictive efficacy was successfully validated in an independent cohort. The analysis has revealed that the high-risk group exhibits a pronounced immunosuppressive phenotype. The study identified 2 additional factors that contribute to the prognosis of cervical cancer: CPE and PGK1 . These factors have been shown to be significantly associated with poor clinical outcomes. In addition, we have identified 2 drugs that may target CPE and PGK1, namely Z-LLNle-CHO and OSU-03-012 . The discovery of these drugs has opened up a new potential pathway for overcoming resistance to immunotherapy. This study addresses a significant research gap concerning HAT in the prognostic assessment of cervical cancer. Furthermore, it offers a crucial molecular basis for clinical decisions regarding individualized therapeutic interventions. |\n| --- |\n| Abbreviations: AUC = area under curve, DEG = differentially expressed gene, FDR = false discovery rate, GEO = Gene Expression Omnibus, GO = gene ontology, GSEA = gene set enrichment analysis, HAT = histone acetylation, HDAC = histone deacetylases, HPA = Human Protein Atlas, HPV = human papillomavirus, KEGG = Kyoto Encyclopedia of Genes and Genomes, ROC = receiver operating characteristic, TCGA = The Cancer Genome Atlas, TME = tumor microenvironment. |\n| Keywords: bioinformatics, cervical cancer, histone acetylation, immunotherapy, prognostic model, tumor microenvironment |\n\n1. Introduction  \nCervical cancer, the 4th most prevalent malignant tumor in the global female population, is a growing epidemiological burden and clinical treatment challenge. According to the World Health Organization Global Cancer Statistics 2022, there will be approximately 660,000 new cases of cervical cancer in that year,[1] and the disease is ranked as the 4th leading cause of cancer-related deaths in women, posing a significant threat to public health. Although the clinical application of immunotherapies such as immune checkpoint inhibitors has significantly improved the 5-year survival rate of patients with cervical cancer in recent years,[2] there  \nare still significant limitations in the existing treatment regimens: about 50% of patients show poor objective remission rates with radiotherapy combined with immunotherapy, and nearly half of the patients are observed to develop secondary drug resistance, which is the most common cause of cancer-related deaths in women. [3] Based on these clinical dilemmas, the development of novel therapeutic strategies to break through the existing therapeutic bottlenecks and improve the prognosis of patients has become a key scientific issue that needs to be urgently solved in translational medicine research and clinical practice.  \nHistone acetylation, a significant epigenetic modification, plays a crucial role in the regulation of diverse cellular  ","cbCaieeb6htoLhHw","https://ap.wps.com/l/cbCaieeb6htoLhHw","pdf",4612701,"English","# Abstract\n## Methodology (data sources and modeling)\n## Immune microenvironment analysis\n## Target screening and validation\n## Prognostic factors and therapeutic implications","[{\"question\":\"What is the main purpose of the study on histone acetylation in cervical cancer?\",\"answer\":\"To evaluate the clinical value of histone acetylation modifications for prognostic assessment and to build a predictive model linked to immunotherapy response and drug targeting.\"},{\"question\":\"How is the prognostic model constructed and what genes are included?\",\"answer\":\"The study formulates a HAT-associated prognostic model using GSE44001 and TCGA-CESC, with 7 pivotal genes selected through Lasso-Cox regression.\"},{\"question\":\"What drugs and prognostic factors does the study identify?\",\"answer\":\"Two potential target drugs are screened using molecular docking, and two additional prognostic factors, CPE and PGK1, are identified as significantly associated with poor clinical outcomes.\"}]","A histone acetylation-based predictive model for immunotherapy response and combinatorial targeting in cervical cancer | PDF",1790173275,48,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f2a6f251ef4ec19128f2fb36e8f82e49.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fed32bf848370d6f96a625ab7a154045.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/259c65c77697bc25e908d88cb8226a70.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f65cea9d33508fbf8b5e0999720c12c3.webp",980,1306]